Home/Filings/4/0001230295-06-000191
4//SEC Filing

SAVIENT PHARMACEUTICALS INC 4

Accession 0001230295-06-000191

CIK 0000722104operating

Filed

Jul 6, 8:00 PM ET

Accepted

Jul 7, 5:16 PM ET

Size

6.1 KB

Accession

0001230295-06-000191

Insider Transaction Report

Form 4
Period: 2006-07-05
HAYDEN BRIAN J
SVP, Chief Financial Officer
Transactions
  • Award

    Option to Purchase Common Stock, $.01 par value

    2006-07-05$5.33/sh+150,000$799,500150,000 total
    Exercise: $5.33From: 2007-07-05Exp: 2016-07-05Common Stock, $.01 par value per share (150,000 underlying)
Footnotes (1)
  • [F1]These options are split between Incentive Stock Options and NonQualified Stock Options as follows: ISOs = 75,044 shs / NQs = 74,956 shs: and will vest in equal 25% increments on each of the first 4 anniversaries of the grant.

Documents

1 file

Issuer

SAVIENT PHARMACEUTICALS INC

CIK 0000722104

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0000722104

Filing Metadata

Form type
4
Filed
Jul 6, 8:00 PM ET
Accepted
Jul 7, 5:16 PM ET
Size
6.1 KB